Aaron Weitzman

3 weeks ago | axios.com | Aaron Weitzman

Axios Pro Exclusive ContentIllustration: Sarah Grillo/AxiosLushi Fertility, a fertility and wellness tech startup, is in talks to be acquired by a Dubai-based family office, two sources tell Axios. Why it matters: The fertility space is growing and attracting substantial investments from venture capital and private equity. Inside the room: A deal, expected to be a mix of cash and equity, is likely to close in the next 60 days, per sources.

3 weeks ago | axios.com | Aaron Weitzman

Axios Pro Exclusive ContentIllustration: Sarah Grillo/AxiosOutro Health, a startup helping patients taper off prescription drugs, is targeting a "large seed" raise in Q4, CEO Brandon Goode tells Axios exclusively. Why it matters: Withdrawal symptoms from antidepressants and other prescription medications often cause severe discomfort — and can be life-threatening. Zoom in: The round will be more than double Outro's $2.2 million pre-seed round last year, Goode says.

3 weeks ago | axios.com | Aaron Weitzman

PhaseV, a clinical trial and development software startup, raised a $50 million Series A, CEO Raviv Pryluk tells Axios exclusively. Why it matters: Pharma's need for efficient clinical trials has never been more stark amid FDA upheaval. Pryluk declined to disclose PhaseV's valuation. Follow the money: Accel and Insight Partners led, joined by existing investors Viola Ventures, EXOR and LionBird.

1 month ago | axios.com | Aaron Weitzman

Tendercare, an adult caregiving services startup, is raising Series A funding, a source familiar tell Axios. The big picture: Today, there are more than 46 million older adults age 65 and older living in the U.S. By 2050, that number is expected to grow to almost 90 million. Inside the room: Tendercare expects to close the round this quarter and is currently targeting single-digit millions, though the final number is yet to be determined, the source says.

1 month ago | axios.com | Aaron Weitzman

Carousel Capital is bringing Palmetto Infusion Services to market later this year, four sources familiar with the situation tell Axios. Why it matters: This will be Carousel's second attempt to exit the business, as it tries to take advantage of PE's recent enthusiasm for infusion companies. Inside the room: Carousel tapped Jefferies to run the auction, per all sources. Palmetto is being marketed on about $30 million of EBITDA, three sources say, with one source noting the number is likely lower.